LOBEF logo

LOBEF Lobe Sciences Ltd.

Other OTC · Biotechnology · Healthcare

$0.03
+0.00 (+1.07%)

Lobe Sciences Ltd. is a life sciences company focused on researching and advancing psychedelic-based medicines. Their primary therapeutic development involves psilocybin-derived treatments combined with N-acetylcysteine, specifically for addressing mild traumatic brain injuries (mTBI) and post-traumatic stress disorder (PTSD). Additionally, they engineer specialized devices aimed at enhancing the …

Market Cap: $9.86Mwww.lobesciences.com

Price

No data yet.

Social Signal Score

44
5d
—
30d
—
60d
50
1 mentions
—
90d
39
5 mentions
—
news: 5

Revenue

$0.00
$0.00$280.2K$560.4K$840.5K
Sep 2016May 2026

Company Profile

CEO
Frederick Dominick Sancilio
Sector
Healthcare
Industry
Biotechnology
Employees
0
Beta
0.29
Country
CA
Piotroski score
2 / 9 (Weak)
Altman Z-score
-10.61
www.lobesciences.com